Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP165094.RAmM2AtJdCWg0wDTBh31wefzampp9jUzhwpifF8YjoELQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP165094.RAmM2AtJdCWg0wDTBh31wefzampp9jUzhwpifF8YjoELQ130_assertion type Assertion NP165094.RAmM2AtJdCWg0wDTBh31wefzampp9jUzhwpifF8YjoELQ130_head.
- NP165094.RAmM2AtJdCWg0wDTBh31wefzampp9jUzhwpifF8YjoELQ130_assertion description "[However, thioredoxin reductase 2 protein was clearly shown to be a biomarker of prostate cancer-associated reactive stroma whose presence distinguishes the stroma associated with benign prostatic hyperplasia from that associated with prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165094.RAmM2AtJdCWg0wDTBh31wefzampp9jUzhwpifF8YjoELQ130_provenance.
- NP165094.RAmM2AtJdCWg0wDTBh31wefzampp9jUzhwpifF8YjoELQ130_assertion evidence source_evidence_literature NP165094.RAmM2AtJdCWg0wDTBh31wefzampp9jUzhwpifF8YjoELQ130_provenance.
- NP165094.RAmM2AtJdCWg0wDTBh31wefzampp9jUzhwpifF8YjoELQ130_assertion SIO_000772 23762225 NP165094.RAmM2AtJdCWg0wDTBh31wefzampp9jUzhwpifF8YjoELQ130_provenance.
- NP165094.RAmM2AtJdCWg0wDTBh31wefzampp9jUzhwpifF8YjoELQ130_assertion wasDerivedFrom befree-20140225 NP165094.RAmM2AtJdCWg0wDTBh31wefzampp9jUzhwpifF8YjoELQ130_provenance.
- NP165094.RAmM2AtJdCWg0wDTBh31wefzampp9jUzhwpifF8YjoELQ130_assertion wasGeneratedBy ECO_0000203 NP165094.RAmM2AtJdCWg0wDTBh31wefzampp9jUzhwpifF8YjoELQ130_provenance.